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ALERT 
Social anxiety disorder (SAD) can significantly impact a patient’s ability to 
function both socially and in his or her work setting. 
 
OVERVIEW 
SAD, also known as social phobia, is a condition that involves the experience of intense fear 
of social situations or interactions (e.g., giving a speech, meeting unfamiliar people). It is 
one of the most prevalent psychiatric disorders.12 
 
In most cases, SAD is chronic. The fear and anxiety experienced in the disorder relates to 
the anticipated observation or scrutiny of others and the assumption that their judgment 
will be negative and cause humiliation or embarrassment. The fear is out of proportion with 
the actual threat and causes significant distress or impairment in certain areas of function, 
including social and occupational. The fear or avoidance is persistent, typically lasting for 6 
or more months, and is not related to another condition, such as an adverse reaction to a 
medication or a panic disorder.1 If the fear is restricted to performing in public, the social 
anxiety should be specified as performance anxiety only.12 
 
When assessing patients for SAD, taking cultural factors into consideration is important. 
Cultural differences may lead to differences in symptoms. An example of the difference is 
found in taijin kyofusho, a culture-specific syndrome in Asian populations that involves the 
patient’s experience of fear of offending or making others uncomfortable, rather than the 
fear of being made to feel extremely uncomfortable or embarrassed. This difference can be 
interpreted in the context of the difference between social norms and values of Asian 
cultures versus Western cultures.8 
 
Women are more likely than men to experience SAD; however, the course of the disorder 
seems similar in men and women related to functional impairment.2 
 
Almost one-third of patients with SAD also experience comorbid depression.9 In addition, 
generalized anxiety disorder is frequently a comorbid condition in children with SAD.7 For 
adolescents and adults, alcohol use disorder is associated with SAD. A national survey 
indicated that almost half of adults with SAD also had alcohol use disorder.3 
 
The two most common periods of onset of social phobia are during mid-adolescence and 
early childhood.5,7 Early onset of SAD is associated with greater severity of signs and 
symptoms, including more significant functional impairment.  
 
Standardized tools can be used to screen patients and assess the severity of symptoms of 
the anxiety disorders. These scales include the Social Interaction Anxiety Scale (SIAS) or 
the Social Phobia Scale (SPS). Scales use self-report or observed data.18 For older adults, 
the Older Adult Social Evaluative Scale (OASES) has demonstrated validity, as has the 
Geriatric Anxiety Scale (GAS).11 
 
SAD treatment includes cognitive behavioral therapy, social skills training, and 
psychoeducation and exposure therapy.14 Medications used to treat SAD include 
antidepressants, benzodiazepines, anticonvulsants, and beta blockers.12 
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EDUCATION 
• Establish a rapport with the patient, family, and designated support person that 
encourages questions. Answer them as they arise. 
• Consider the patient’s, family’s, and designated support person’s values and goals in the 
decision-making process. 
• Assist the patient, family, and designated support person to recognize signs and 
symptoms of acute exacerbation of the illness.  
• Explain the manifestations of the illness and expected progression of symptoms if the 
patient experiences a relapse. Describe what the family and designated support person 
are likely to see, hear, and experience (e.g., fear or embarrassment in social situations, 
excessive shyness, and avoidance of unfamiliar activities).12 Advise the patient, family, 
and designated support person of steps to take if relapse occurs. 
• Explain to the patient, family, and designated support person that the main goal is to 
provide a safe, secure place to receive treatment. 
• Explain how the behavioral health unit may be different than other settings. Interaction 
is promoted between patients and staff, and group meetings are encouraged. To ensure 
patients’ safety, they are checked on frequently throughout the day. 
• Educate the family and designated support person regarding the nature of the 
psychiatric illness and expected signs and symptoms of SAD (e.g., social isolation, 
excessive fear embarrassment in social situations, impaired school and work 
performance).12 
• Educate the patient, family, and support person about positive coping strategies such as 
cognitive reappraisal, problem-solving, and acceptance.6,16 
• Assist the patient, family, and designated support person to engage and participate as 
drivers of the plan of care. 
• Explain the importance of following the medication regimen as ordered. The patient 
should not alter the dosage or stop taking the medication even if symptoms have 
subsided and he or she is feeling better. 
 
ASSESSMENT  
1. Perform hand hygiene.  
2. Introduce yourself to the patient, family, and designated support person. 
3. Verify the correct patient using two identifiers. 
4. Assess the patient’s mental status and ability to understand information and participate 
in decisions. Include the patient as much as possible in all decisions.  
5. Consider that extreme states of anxiety may negatively impact the patient’s ability to 
accurately hear and understand information. 
6. Assess the patient for suicidal or homicidal ideation or thoughts of self-harm. 
7. Assess the patient for signs and symptoms of SAD, including physical signs and 
symptoms related to arousal, tachycardia, blushing, trembling, and sweating; behavioral 
signs and symptoms, including avoidance, refusing to eat meals with others, avoiding eye 
contact or participation in groups; and cognitive signs and symptoms, including negative 
thoughts, embarrassment, and shame.13 
8. Assess the patient for comorbid disorders, such as substance use or alcohol use disorder, 
generalized anxiety disorder, or depression. Assess the patient for use of alcohol or drugs as 
a way to reduce anxiety and mask signs and symptoms in social situations.3 
9. Assess the patient’s use of coping strategies and consider whether they are adaptive 
(e.g., cognitive reappraisal, problem-solving, acceptance) or maladaptive (e.g., avoidance, 
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suppression, rumination); determine how successful these coping strategies are in helping 
the patient reduce symptoms of anxiety.6,16 
10. Evaluate the patient’s, family’s, and designated support person’s understanding of the 
patient’s illness.  
11. Assess for a possible family history of SAD. Genetic factors may play a role in the 
development of the disorder.12 
12. Assess and discuss the patient’s goal for treatment.  
13. Collaborate with the patient, family, and designated support person to develop a plan of 
care. 
14. Identify the patient’s psychiatric advance directives, if available. 
15. Determine the patient’s desire for the family or designated support person to be kept 
informed and involved in treatment. 
16. Determine the family’s or designated support person’s ability to support the patient 
during treatment. 
 
STRATEGIES  
1. Perform hand hygiene. 
2. Verify the correct patient using two identifiers. 
3. Assess the patient for suicidal or homicidal ideation or thoughts of self-harm, and if 
present, implement appropriate precautions based on the patient’s status.  
4. Explain the strategies to the patient, family, and designated support person and ensure 
that they agree to treatment.  
5. Allow the patient adequate time to answer questions. 
 
Rationale: Pressuring the patient to answer questions or appearing to rush 
the assessment process can create more discomfort for him or her and should 
be avoided. 
 
6. Maintain a calm, collaborative communication approach, avoiding the use of coercion. 
7. Create an environment of trust that allows the development of a therapeutic relationship. 
8. Orient the patient to the unit. Include discussion of unit routines, guidelines, patients’ 
rights and expectations, and schedules. Inform the patient that he or she will be checked on 
frequently throughout the stay. 
9. Create an environment that advocates for the patient’s needs using an interdisciplinary 
team. Engage the team in collaborative assessment and treatment planning with the 
patient. 
10. Engage the patient in treatment, including participation in therapeutic groups and 
individual sessions. Understand that the patient may not be comfortable participating in 
groups when first admitted, and that he or she may need to work with health care team 
members to gain a level of comfort to integrate into a group program. 
11. Administer psychiatric medications as ordered and monitor the patient’s response to the 
medications. 
12. Monitor the patient’s responses and social interactions in the milieu; reinforce 
appropriate social skills.  
13. Identify issues related to the patient’s SAD and his or her ability to interact in the milieu 
and in groups. 
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Rationale: Patients who experience signs and symptoms of social anxiety may 
be too uncomfortable to participate in group activities or express themselves 
openly to others for fear of being judged. 
 
14. Identify comorbid disorders that may impact the patient’s ability to participate in 
treatment. 
 
Rationale: Patients who are experiencing depression may lack the motivation 
to participate in treatment. In addition, patients who are substance or alcohol 
users may experience withdrawal when admitted and must be monitored for 
signs and symptoms of withdrawal. 
 
15. Identify safety behaviors the patient uses to safeguard against feared outcomes. Safety 
behaviors may include keeping his or her hands in pockets to hide shaking, wearing heavy 
makeup to cover blushing, pretending not to see someone or to be disinterested, avoiding 
eye contact or sitting in an inconspicuous seat, being a passive spectator, walking with the 
head down or laughing to hide nervousness.10  
16. Consider using a standardized scale to assess the patient’s use of safety behaviors, such 
as the Social Phobia Safety Behaviours Scale (SPSBS).10 
 
Rationale: Use of safety behaviors may, at times, be maladaptive and prevent 
the patient from addressing the issues related to social anxiety. Safety 
behaviors may also have negative interpersonal effects.  
 
17. Consider using a standardized assessment tool to measure social anxiety, such as the 
SIAS or the SPS.18 
18. Implement appropriate precautions based on the patient’s status. 
19. Respond to crisis in a calm, therapeutic, and nonthreatening manner. Use the least 
restrictive interventions to prevent harm to patients or staff. 
20. Collaborate with the patient, family, designated support person, and team in planning 
for patient discharge and follow-up care. 
21. Provide the appropriate education related to medications, crisis management, and 
follow-up care to the patient, family, and designated support person at the time of 
discharge. 
22. Explain to the patient, family, and designated support person that ongoing treatment is 
vital to continuing recovery. Making and keeping follow-up appointments is critical. 
23. Perform hand hygiene. 
24. Document the strategies in the patient’s record. 
 
REASSESSMENT 
1. Reassess the patient’s pain status and provide appropriate pain management (e.g., 
medication, relaxation, mindfulness skills). 
2. Reassess the patient for an increase in signs and symptoms of anxiety or use of safety 
behaviors. 
 
EXPECTED OUTCOMES 
• Patient experiences a reduction in signs and symptoms of SAD and is able to collaborate 
with the health care team member in the full assessment process. 
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UNEXPECTED OUTCOMES 
• Patient is too anxious to participate in the assessment process. 
 
DOCUMENTATION 
• Patient, family, and support person education 
• Patient’s behaviors and response to interventions 
• Patient’s progress toward goals 
• Assessment of pain, treatment if necessary, and reassessment 
 
ADOLESCENT CONSIDERATIONS 
• Paranoia and social anxiety are closely related. Adolescents with SAD experience 
paranoid thoughts more frequently and intensely than the general population.15 A lack of 
understanding of this consideration may lead to inaccurate diagnoses in adolescents.15 
 
OLDER ADULT CONSIDERATIONS 
• Although anxiety disorders are prevalent among older adults, SAD is not among the 
most common ones. Older adults more commonly experience generalized anxiety 
disorder or specific phobias.4 
 
SPECIAL CONSIDERATIONS 
• SAD rates are significantly higher among all age groups of patients with comorbid 
autism spectrum disorder than among the general population.17 
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